UTIs are the cause of roughly 8 million emergency room visits and 100,000 hospitalizations in the US each year, GSK said.

The Advisory Committee on Immunization Practices (ACIP) has voted to expand the recommended use of GSK’s AREXVY (Respiratory ...

The U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) has ...

In a report released today, Jo Walton from UBS maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target of ...

Company has Deloitte Haskins & Sells LLP as its auditors. As on 31-03-2025, the company has a total of 16.94 Crore shares outstanding.GSK Pharma Share Price Today is Rs. 2818.20. On previous day, the ...

In a report released today, James Gordon from J.P. Morgan maintained a Sell rating on GlaxoSmithKline (GSK – Research Report), with a price ...

GSK PLC closed 25.31% below its 52-week high of £18.24, which the company reached on May 16th.

Many novel drugs are more relevant for subspecialists, but of the six first-in-class medications approved by the US Food and ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Alector has completed subject enrolment in the 76-week, randomised, Phase II PROGRESS-AD trial, which is assessing the ...

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has authorised GSK’s Blenrep for treating multiple ...

China’s response to new United States (U.S.) tariffs could complicate the supply of important medicines, an analysis of data ...